From Metro today:
Leading cancer charities have expressed their alarm that a no-deal Brexit could have a grave impact on ‘lifesaving research’ to treat childhood cancers. It comes after the publication of the government’s Yellowhammer papers, which warned that medicines would be ‘particularly vulnerable to severe delays’ in the event of Britain crashing out of the EU without a deal. The documents also highlighted that ‘three-quarters of medicines’ come from the EU. Cancer charities are now calling on the government to take steps to ensure the ‘supply of medicines and lifesaving research’ which are so vital to treating children’s cancers, are not harmed by a no-deal Brexit, after Boris Johnson reaffirmed his commitment to leaving the EU with or without a deal on October 31. Cancer research UK says that more than a quarter of the clinical trials that it funds involved at least one other EU country, which are ‘particularly important for rare and children’s cancers’. The charity’s head of policy, Emlyn Samuel, told Metro.co.uk: ‘It’s imperative that a “no-deal” Brexit does not disrupt the supply of medicines and medicinal products to the UK, or threaten vital international research collaboration. ‘More than a quarter of the clinical trials that Cancer Research UK funds involve at least one other EU country, and these are particularly important for rare and children’s cancers.
Read more: metro.co.uk/2019/09/15/brexit-delay-lifesaving-cancer-treatment-will-hit-children-hardest-10747050/?ito=article.desktop.share.top.facebook&fbclid=IwAR0bfbCnclaLyBBZ7fHcqo3lKqOYA-SuHOfn6cpv4NZTgVTAnoxk0ZxJN2c?ito=cbshare
Twitter: twitter.com/MetroUK | Facebook: www.facebook.com/MetroUK/
Being quizzed by chemist's assistant in Boots.
Nicola Sturgeon’s husband re-arrested
To think that London, or anywhere else for that matter, does not belong to any one demographic